Salmonellavaccines for use in humans: present and future perspectives
Open Access
- 1 November 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 26 (4) , 339-353
- https://doi.org/10.1111/j.1574-6976.2002.tb00619.x
Abstract
In recent years there has been significant progress in the development of attenuated Salmonella enterica serovar Typhi strains as candidate typhoid fever vaccines. In clinical trials these vaccines have been shown to be well tolerated and immunogenic. For example, the attenuated S. enterica var. Typhi strains CVD 908-htrA (aroC aroD htrA), Ty800 (phoP phoQ) and χ4073 (cya crp cdt) are all promising candidate typhoid vaccines. In addition, clinical trials have demonstrated that S. enterica var. Typhi vaccines expressing heterologous antigens, such as the tetanus toxin fragment C, can induce immunity to the expressed antigens in human volunteers. In many cases, the problems associated with expression of antigens in Salmonella have been successfully addressed and the future of Salmonella vaccine development is very promising.Keywords
This publication has 99 references indexed in Scilit:
- Bacteremia Associated with Live Attenuated χ8110 Salmonella enterica serovar Typhi ISP1820 in Healthy Adult VolunteersClinical Immunology, 2001
- Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicanaVaccine, 1998
- Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi TY2 χ4297 (Δcya Δcrp Δasd): safety and immunogenicity in miceVaccine, 1997
- Induction of Mucosal and Systemic Responses against Human Immunodeficiency Virus Type 1 Glycoprotein 120 in Mice after Oral Immunization with a Single Dose of aSalmonella-HIV VectorAIDS Research and Human Retroviruses, 1997
- AttenuatedSalmonella typhimuriumContaining Interleukin-2 Decreases MC-38 Hepatic Metastases: A Novel Anti-tumor AgentCancer Biotherapy & Radiopharmaceuticals, 1996
- Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutantVaccine, 1996
- Differential persistence, immunogenicity and protective capacity of temperature-sensitive mutants ofSalmonella enteritidisafter oral or intragastric administration to miceFEMS Immunology & Medical Microbiology, 1993
- Recombination‐deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophagesMolecular Microbiology, 1993
- Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine developmentGene, 1991
- Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trialVaccine, 1990